Literature DB >> 19783010

Pulmonary complications after lung resection in the absence of chronic obstructive pulmonary disease: the predictive role of diffusing capacity.

Mark K Ferguson1, Henning A Gaissert, Joshua D Grab, Shubin Sheng.   

Abstract

OBJECTIVE: Diffusing capacity is not routinely used in assessing risk of lung resection, perhaps owing to uncertainty as to whether patients with normal spirometric results require additional evaluation. We determined whether diffusing capacity is predictive of pulmonary complications after lung resection in patients with normal spirometric results.
METHODS: We reviewed outcomes of major lung resection in The Society of Thoracic Surgeons General Thoracic Surgery Database from 2002 to 2008 to determine the relationship of diffusing capacity (expressed as percent of predicted) to postoperative pulmonary complications stratified by chronic obstructive pulmonary disease status.
RESULTS: Percent of predicted diffusing capacity was measured in 7891 (57%) patients. There were 3905 women and 3986 men with a mean age of 66.3 +/- 10.6 years who underwent lobectomy (6904; 87.5%), bilobectomy (463; 5.9%), and pneumonectomy (524; 6.6%). Chronic obstructive pulmonary disease was identified in 2711 (34.4%) patients. Pulmonary complications occurred in 13%, and the operative mortality was 1.9%. Percent of predicted diffusing capacity was strongly associated with the development of pulmonary complications (odds ratio, 1.12 per 10-point decrease; P < .0001). Decreasing percent of predicted diffusing capacity was incrementally related to an increased incidence of pulmonary complications regardless of chronic obstructive pulmonary disease status. There was no apparent interaction between percent of predicted diffusing capacity and chronic obstructive pulmonary disease status in the predictive model.
CONCLUSIONS: Percent of predicted diffusing capacity predicts pulmonary complications after lung resection in patients without chronic obstructive pulmonary disease. We recommend measurement of diffusing capacity in lung resection candidates, regardless of chronic obstructive pulmonary disease, as an important element in the accurate assessment of operative risk.

Entities:  

Mesh:

Year:  2009        PMID: 19783010     DOI: 10.1016/j.jtcvs.2009.05.045

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  22 in total

1.  Diffusing capacity predicts long-term survival after lung resection for cancer.

Authors:  Mark K Ferguson; James J Dignam; Juned Siddique; Wickii T Vigneswaran; Amy D Celauro
Journal:  Eur J Cardiothorac Surg       Date:  2012-02-24       Impact factor: 4.191

2.  Worse Prognosis for Stage IA Lung Cancer Patients with Smoking History and More Severe Chronic Obstructive Pulmonary Disease.

Authors:  Yukihiro Yoshida; Hidenori Kage; Tomohiro Murakawa; Yasunori Sato; Satoshi Ota; Masashi Fukayama; Jun Nakajima
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-01-26       Impact factor: 1.520

3.  Applicability of Pulmonary Lobectomy in Treating Metastatic Lung Tumors.

Authors:  Tatsuro Okamoto; Hirokazu Kitahara; Shinichiro Shimamatsu; Yosuke Morodomi; Tetsuzo Tagawa; Yoshihiko Maehara
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-01-26       Impact factor: 1.520

4.  Does surgeon experience affect outcomes in pathologic stage I lung cancer?

Authors:  Paul J Scheel; Traves D Crabtree; Jennifer M Bell; Christine Frederiksen; Stephen R Broderick; A Sasha Krupnick; Daniel Kreisel; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  J Thorac Cardiovasc Surg       Date:  2014-12-20       Impact factor: 5.209

5.  Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis.

Authors:  Takashi Eguchi; Sarina Bains; Ming-Ching Lee; Kay See Tan; Boris Hristov; Daniel H Buitrago; Manjit S Bains; Robert J Downey; James Huang; James M Isbell; Bernard J Park; Valerie W Rusch; David R Jones; Prasad S Adusumilli
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

Review 6.  Preoperative functional workup for patients with advanced lung cancer.

Authors:  Alessandro Brunelli
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

7.  Impact of pulmonary function on pulmonary complications after robotic-assisted thoracoscopic lobectomy.

Authors:  Christopher Cao; Brian E Louie; Franca Melfi; Giulia Veronesi; Rene Razzak; Gaetano Romano; Pierluigi Novellis; Neel K Ranganath; Bernard J Park
Journal:  Eur J Cardiothorac Surg       Date:  2020-02-01       Impact factor: 4.191

8.  Reduction of air leakage using linear staple device with bioabsorbable polyglycolic acid felt for pulmonary lobectomy.

Authors:  Hiroyuki Deguchi; Makoto Tomoyasu; Wataru Shigeeda; Yuka Kaneko; Hironaga Kanno; Hajime Saito
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-09-20

9.  Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis.

Authors:  DuyKhanh P Ceppa; Andrzej S Kosinski; Mark F Berry; Betty C Tong; David H Harpole; John D Mitchell; Thomas A D'Amico; Mark W Onaitis
Journal:  Ann Surg       Date:  2012-09       Impact factor: 12.969

10.  National cooperative group trials of "high-risk" patients with lung cancer: are they truly "high-risk"?

Authors:  Varun Puri; Traves D Crabtree; Jennifer M Bell; Daniel Kreisel; Alexander S Krupnick; Stephen Broderick; G Alexander Patterson; Bryan F Meyers
Journal:  Ann Thorac Surg       Date:  2014-02-16       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.